Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 03937C105 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
American Century Investment Management, Inc.
13G/A
Amendment 1
|
6.9% |
8/14/2026
Event 6/30/2026
|
|
| American Century ETF Trust | 5.3% | ||
| American Century Investment Management, Inc. | 6.9% | ||
| American Century Companies, Inc. | 6.9% | ||
| Stowers Institute for Medical Research | 6.9% | ||
| Invesco Ltd. 13G | 7.4% |
8/13/2026
Event 6/30/2026
|
|
|
FMR LLC
13G/A
Amendment 1
|
0.6% |
8/6/2026
Event 6/30/2026
|
|
| FMR LLC | 0.6% | ||
| Abigail P. Johnson | 0.6% | ||
| AllianceBernstein L.P. 13G/A Amendment 3 | 4.6% |
5/18/2026
Event 3/31/2026
|
|
|
FMR LLC
13G
|
5.8% |
5/6/2026
Event 3/31/2026
|
|
| FMR LLC | 5.8% | ||
| Abigail P. Johnson | 5.8% | ||
| Vanguard Capital Management LLC 13G | 5.3% |
4/29/2026
Event 3/31/2026
|
|
| Vanguard Portfolio Management LLC 13G | 5.7% |
4/28/2026
Event 3/31/2026
|
|
| Vanguard Group Inc 13G/A Amendment 14 | 0% |
3/26/2026
Event 3/13/2026
|
|
|
American Century Investment Management, Inc.
13G
|
5.8% |
2/13/2026
Event 12/31/2025
|
|
| American Century Investment Management, Inc. | 5.8% | ||
| American Century Companies, Inc. | 5.8% | ||
| Stowers Institute for Medical Research | 5.8% | ||
| AllianceBernstein L.P. 13G/A Amendment 2 | 7.0% |
8/13/2025
Event 6/30/2025
|
|
| BlackRock, Inc. 13G/A Amendment 2 | 14.7% |
7/18/2025
Event 6/30/2025
|
|
| AllianceBernstein L.P. 13G/A Amendment 1 | 11.5% |
5/14/2025
Event 3/31/2025
|
|
|
FMR LLC
13G/A
Amendment 1
|
3.7% |
5/12/2025
Event 3/31/2025
|
|
| FMR LLC | 3.7% | ||
| Abigail P. Johnson | 3.7% | ||
| Dimensional Fund Advisors LP 13G/A Amendment 16 | 6.3% |
4/15/2025
Event 3/31/2025
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 7 | 26.3 k | $3.35 M |
| 2026 Q2 | 343 | 26.8 M | $3.32 B |
| 2026 Q1 | 287 | 23.1 M | $2.25 B |
| 2025 Q4 | 273 | 23.4 M | $1.74 B |
| 2025 Q3 | 282 | 22.5 M | $1.58 B |
| 2025 Q2 | 287 | 22.9 M | $1.77 B |
| 2025 Q1 | 282 | 23.5 M | $1.66 B |
| 2024 Q4 | 298 | 23.5 M | $2.20 B |
| 2024 Q3 | 313 | 23.7 M | $2.57 B |
| 2024 Q2 | 326 | 24.7 M | $2.65 B |
| 2024 Q1 | 345 | 24.5 M | $3.48 B |
| 2023 Q4 | 330 | 24.4 M | $2.93 B |
| 2023 Q3 | 304 | 23.3 M | $2.37 B |
| 2023 Q2 | 292 | 22.9 M | $2.27 B |
| 2023 Q1 | 294 | 21.7 M | $1.98 B |
| 2022 Q4 | 272 | 22.5 M | $1.57 B |
| 2022 Q3 | 275 | 21.7 M | $1.58 B |
| 2022 Q2 | 264 | 21.8 M | $1.53 B |
| 2022 Q1 | 279 | 21.8 M | $1.76 B |
| 2021 Q4 | 304 | 22.3 M | $2.68 B |
| 2021 Q3 | 236 | 22.9 M | $1.87 B |
| 2021 Q2 | 233 | 23.0 M | $1.34 B |
| 2021 Q1 | 200 | 22.3 M | $1.63 B |
| 2020 Q4 | 189 | 24.4 M | $1.04 B |
| 2020 Q3 | 183 | 22.5 M | $702 M |
| 2020 Q2 | 168 | 22.7 M | $603 M |
| 2020 Q1 | 163 | 22.3 M | $392 M |
| 2019 Q4 | 164 | 23.2 M | $641 M |
| 2019 Q3 | 182 | 23.3 M | $711 M |
| 2019 Q2 | 196 | 23.9 M | $669 M |
| 2019 Q1 | 211 | 25.3 M | $778 M |
| 2018 Q4 | 223 | 24.4 M | $835 M |
| 2018 Q3 | 223 | 24.2 M | $1.17 B |
| 2018 Q2 | 232 | 24.8 M | $1.13 B |
| 2018 Q1 | 199 | 23.6 M | $756 M |
| 2017 Q4 | 170 | 22.7 M | $811 M |
| 2017 Q3 | 164 | 23.0 M | $768 M |
| 2017 Q2 | 148 | 21.9 M | $450 M |
| 2017 Q1 | 170 | 22.7 M | $591 M |
| 2016 Q4 | 176 | 23.8 M | $658 M |
| 2016 Q3 | 149 | 21.7 M | $414 M |
| 2016 Q2 | 154 | 21.8 M | $354 M |
| 2016 Q1 | 160 | 22.6 M | $487 M |
| 2015 Q4 | 189 | 22.3 M | $477 M |
| 2015 Q3 | 179 | 23.1 M | $596 M |
| 2015 Q2 | 180 | 23.9 M | $759 M |
| 2015 Q1 | 187 | 24.4 M | $926 M |
| 2014 Q4 | 208 | 24.9 M | $1.16 B |
| 2014 Q3 | 211 | 25.2 M | $941 M |
| 2014 Q2 | 185 | 23.0 M | $998 M |
| 2014 Q1 | 8 | 967 k | $35.7 M |